QQ客服 官方微博 反馈留言

	ARNT/HIF-1 beta links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma
	Wu, Chuan; Yang, Ting; Liu, Yingmin; Lu, Yicheng; Yang, Yanping; Liu, Xiaobo; Liu, Xuelian; Ye, Long; Sun, Yue; Wang, Xue
刊名	CANCER MEDICINE
	2018
卷号	7期号:8
关键词	1q21 gain ARNT/HIF-beta drug resistance hypoxia multiple myeloma
ISSN号	2045-7634
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3537030
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Wu, Chuan,Yang, Ting,Liu, Yingmin,et al. ARNT/HIF-1 beta links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma[J]. CANCER MEDICINE,2018,7(8).
APA	Wu, Chuan.,Yang, Ting.,Liu, Yingmin.,Lu, Yicheng.,Yang, Yanping.,...&Li, Wei.(2018).ARNT/HIF-1 beta links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma.CANCER MEDICINE,7(8).
MLA	Wu, Chuan,et al."ARNT/HIF-1 beta links high-risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma".CANCER MEDICINE 7.8(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。